Variant Summary
- HGVS
- —
- Variant Type(s)
- transcript_amplification
- Evidence Items
- 5
Evidence Level Distribution
Level B: 1Level D: 4
Evidence Items
Showing CIViC evidence rows where gene = CCNE1 and variant = Amplification.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| D | Predictive | Supports | Sensitivity/Response | Ovarian Serous Cystadenocarcinoma | Akt Inhibitor MK2206,Dinaciclib | 4 |
| B | Prognostic | Supports | Poor Outcome | Ovarian Carcinoma | 4 | |
| D | Predictive | Supports | Sensitivity/Response | Ovarian Carcinoma | Camonsertib,Lunresertib | 3 |
| D | Predictive | Supports | Sensitivity/Response | Endometrial Carcinoma | Camonsertib,Lunresertib | 3 |
| D | Predictive | Supports | Resistance | Estrogen-receptor Positive Breast Cancer | Palbociclib | 3 |